Separation Systems for Commercial Biotechnology Market to Exceed US$ 19,200 Million by 2023

New York, February 06: Market Research Engine has published a new report titled as “Separation Systems for Commercial Biotechnology Market By Product Type (MACS & FACS systems, Liquid chromatography, Electrophoresis instruments, Flow cytometer instruments, centrifugation systems, DNA microarray instruments, Protein microarray instruments, biochips, lab-on-a-chip); By End Users (Pharmaceuticals, Food & Cosmetics, Energy, Life Sciences Research and Agriculture) - Global Industry Analysis and Forecast 2015 - 2023”

How Big is the Separation Systems for Commercial Biotechnology Market?

The Separation Systems For Commercial Biotechnology Market was valued at US$ 10,660 Million in 2014 and is projected to grow at a CAGR of more than 6.5% in the given forecast period to cross US$ 19,200 Million by 2023.

Browse Full Report: https://www.marketresearchengine.com/reportdetails/separation-systems-for-commercial-biotechnology-market

Separation systems play a very important function in business biotechnology procedure. This system produces the desired goods from small to large amount and has large area of appliances. Electrophoresis instruments, centrifugation system, flow cytometer instruments, membrane filters and liquid chromatography are the main sectors of the market. Every systems uses specific method to hold separations in the energy industry, agriculture, biopharmaceutical and biotechnology, etc. Chromatography frameworks have increased across the board prominence because of the presentation of novel advances in chromatographic instruments and consumables. Flow cytometry has risen as a main, application-rich innovation. Expanding interest and headway of microarray innovation supports advertise development. Research center computerization has empowered researchers to process tests requiring little to no effort, and hence has assumed a noteworthy part in the examinations.

The major driving factors of separation systems for commercial biotechnology market are as follows:

Increasing contribution and support of government agencies.
Rising awareness through exhibitions and conferences.
Technological developments.

The restraining factors of separation systems for commercial biotechnology market are as follows:

Patent rights above MACS technique.
Need of innovation in electrophoresis equipment technology.
High cost of technologies and system.

The separation systems for commercial biotechnology market are segmented on the lines of its product, end user and regional. Based on product segmentation the market covers MACS and FACS system, protein microarray, flow cytometry, membrane filters, electrophoresis units, liquid chromatography, centrifugation systems and others such as biochips, lab-on-a-chip, etc. Under end user segmentation it covers energy, agriculture, food and cosmetics, pharmaceuticals, life sciences research. The separation systems for commercial biotechnology market’s geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

Download Free Sample Report: https://www.marketresearchengine.com/requestsample/separation-systems-for-commercial-biotechnology-market

This report provides:

1) An overview of the global market for separation systems for commercial biotechnology and related technologies.

2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2023.

3) Identifications of new market opportunities and targeted promotional plans for separation systems for commercial biotechnology.

4) Discussion of research and development, and the demand for new products and new applications.

5) Comprehensive company profiles of major players in the industry.

REPORT SCOPE:

The scope of the report includes a detailed study of global and regional markets for Separation Systems for Commercial Biotechnology Marketfor variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Danaher Corporation, Thermo Fisher Scientific, Inc., Waters Corporation, Becton, Dickinson and Company, GE Healthcare and Merck KGaA. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

The Separation systems for commercial biotechnology Market has been segmented as below:

By Product Segment Analysis

MACS and FACS System
Protein Microarray
Flow Cytometry
Membrane Filters
Electrophoresis Units
Liquid Chromatography
Centrifugation Systems
Others (biochips, lab-on-a-chip, etc.)

By End User Analysis

Energy
Agriculture
Food and Cosmetics
Pharmaceuticals
Life Sciences Research

By Regional Analysis

North America
Europe
Asia-Pacific
Rest of the World

About MarketResearchEngine.com

Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862, +91-860-565-7204
Country: United States
Website: https://www.marketresearchengine.com/

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.